(Q34236416)

31 July 2017

title

3-T proton magnetic spectroscopy in unmedicated first episode psychosis: a focus on creatine (English)

1 reference

31 July 2017

1 reference

6

Scot E Purdon

1 reference

31 July 2017

Philip G Tibbo

1

1 reference

31 July 2017

Denise Bernier

2

1 reference

31 July 2017

Christopher C Hanstock

3

1 reference

31 July 2017

Peter Seres

4

1 reference

31 July 2017

Bonnie Lakusta

5

1 reference

31 July 2017

publication date

17 April 2012

1 reference

Magnetic Resonance in Medicine

31 July 2017

published in

1 reference

31 July 2017

volume

69

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

613-620

1 reference

Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy

31 July 2017

cites work

1 reference

Developmental reflexes and 31P Magnetic Resonance Spectroscopy of basal ganglia in antipsychotic-naive schizophrenia.

21 January 2018

1 reference

MRI volumetric and 31P MRS metabolic correlates of caudate nucleus in antipsychotic-naïve schizophrenia.

21 January 2018

1 reference

High energy phosphate abnormalities normalize after antipsychotic treatment in schizophrenia: a longitudinal 31P MRS study of basal ganglia

21 January 2018

1 reference

Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction

21 January 2018

1 reference

Creatine abnormalities in schizophrenia and bipolar disorder

21 January 2018

1 reference

Hippocampal age-related changes in schizophrenia: a proton magnetic resonance spectroscopy study.

21 January 2018

1 reference

A 1H-MRS investigation of the medial temporal lobe in antipsychotic-naïve and early-treated first episode psychosis

21 January 2018

1 reference

Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients

21 January 2018

1 reference

Proton NMR chemical shifts and coupling constants for brain metabolites

21 January 2018

1 reference

Creatine transporters: a reappraisal.

21 January 2018

1 reference

Functions and effects of creatine in the central nervous system.

21 January 2018

1 reference

Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis

21 January 2018

1 reference

Creatine kinase BB in brain in schizophrenia.

21 January 2018

1 reference

A model of the coupling between brain electrical activity, metabolism, and hemodynamics: application to the interpretation of functional neuroimaging

21 January 2018

1 reference

Biexponential transverse relaxation (T(2)) of the proton MRS creatine resonance in human brain

21 January 2018

1 reference

Discovery and development of integrative biological markers for schizophrenia.

21 January 2018

1 reference

Self-reflection and the brain: a theoretical review and meta-analysis of neuroimaging studies with implications for schizophrenia.

21 January 2018

1 reference

Medial prefrontal cortex pathology in schizophrenia as revealed by convergent findings from multimodal imaging

21 January 2018

1 reference

Automatic, localized in vivo adjustment of all first- and second-order shim coils

21 January 2018

1 reference

Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo.

21 January 2018

1 reference

3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia

21 January 2018

1 reference

Magnetization transfer MRS.

21 January 2018

1 reference

Automatic quantitation of localized in vivo 1H spectra with LCModel.

21 January 2018

1 reference

Response of metabolites with coupled spins to the STEAM sequence.

21 January 2018

1 reference

A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF).

21 January 2018

1 reference

On the validity of the Beck Depression Inventory. A review

21 January 2018

1 reference

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

T2 relaxation time abnormalities in bipolar disorder and schizophrenia

21 January 2018

1 reference

Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T.

21 January 2018

1 reference

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.

21 January 2018

1 reference

Neurodevelopmental liability to schizophrenia: the complex mediating role of age at onset and premorbid adjustment.

21 January 2018

1 reference

Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis

21 January 2018

1 reference

N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia

21 January 2018

1 reference

Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study.

21 January 2018

1 reference

MR spectroscopic evaluation of N-acetylaspartate's T2 relaxation time and concentration corroborates white matter abnormalities in schizophrenia

21 January 2018

1 reference

Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers

21 January 2018

1 reference

Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study

21 January 2018

1 reference

Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls

21 January 2018

1 reference

Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).

21 January 2018

1 reference

Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study

21 January 2018

1 reference

Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

21 January 2018

1 reference

Single-voxel 1H PRESS at 4.0 T: precision and variability of measurements in anterior cingulate and hippocampus.

21 January 2018

1 reference

Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia

21 January 2018

1 reference

Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood

21 January 2018

1 reference

1H-MR spectroscopy in ultra-high risk and first episode stages of schizophrenia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MRM.24291

1 reference

31 July 2017

1 reference